The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1341
June 28, 2010
View Complete Issue         Table of Contents 2019 
A Sumatriptan Needle-Free Injector for Migraine
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
A Sumatriptan Needle-Free Injector for Migraine
June 28, 2010 (Issue: 1341)
Sumatriptan was first marketed in the US in 1993 as Imitrex for subcutaneous injection, followed by tablets for oral administration and then by a nasal spray. It is one of seven serotonin receptor agonists (“triptans”) marketed in the US for...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: A Sumatriptan Needle-Free Injector for Migraine
Article code: 1341c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.